Wolfram Syndrome
·MeSH: Wolfram Syndrome
Prevalence
0.5 / 100K
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
Phase 2(1)
| Drug | Company |
|---|---|
| AMX0035 | Amylyx Pharmaceuticals, Inc. (AMLX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Wolfram Syndrome?
BioSniper tracks 2 drugs in development for Wolfram Syndrome across 1 company.
How many clinical trials target Wolfram Syndrome?
There are 1 clinical trial targeting Wolfram Syndrome tracked by BioSniper.
What is the prevalence of Wolfram Syndrome?
The estimated prevalence of Wolfram Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Wolfram Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis